Our Products

Imatinib Tablets IP 400 mg is a medication used primarily to treat various types of cancer, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and certain other cancers. It is a tyrosine kinase inhibitor that works by blocking the action of specific enzymes (tyrosine kinases) involved in the growth of cancer cells. In particular, Imatinib targets the BCR-ABL protein in CML and the c-KIT protein in GISTs, helping to prevent the growth and spread of these cancers.

The 400 mg dosage is typically taken once daily with food and a full glass of water, as prescribed by a healthcare provider. Common side effects may include nausea, vomiting, fatigue, muscle cramps, and swelling. It is important for patients to have regular check-ups and blood tests to monitor the effectiveness of treatment and manage any potential side effects.